Upregulation of HTRA1 mediated by the lncRNA NEAT1/miR-141-3p axis contributes to endometriosis development through activating NLRP3 inflammasome-mediated pyroptotic cell death and cellular inflammation
article
OA: closed
CC0
⤵ 1 in-corpus citation
Abstract
The present study identified a novel upstream long chain non-coding (lncRNA) NEAT1/miR-141-3p/HTRA1 axis that regulated the activation of NLR family pyrin domain containing 3 (NLRP3) inflammasome to modulate endometriosis (EM) development. Specifically, clinical data suggested that the expression of NLRP3 and apoptosis-associated speck-like protein containing CARD (ASC), the cleavage of caspase-1 and gasdermin D (GSDMD), and the production of inflammatory cytokines (interleukin (IL)-1β, IL-6, tumor necrosis factor (TNF)-α, and IL-18) were all significantly increased in the ectopic endometrium (EE) tissues, compared to the normal endometrium (NE) tissues. Then, through analyzing the datasets from GEO database (GSE2339, GSE58178, and GSE7305) using the GEO2R bioinformatics tools, we verified that HtrA Serine Peptidase 1 (HTRA1) was especially enriched in the EE tissues compared to the NE tissues. To further confirm the biological functions of HTRA1, HTRA1 was overexpressed or downregulated in primary human endometrial stromal cells (hESCs) isolated from NE tissues or EE tissues, respectively. The results showed that upregulation of HTRA1 activated NLRP3 inflammasome-mediated pyroptotic cell death and cellular inflammation in NE-derived hESCs, whereas silencing of HTRA1 played an opposite role in EE-derived hESCs. In addition, the lncRNA NEAT1/miR-141-3p axis was screened as the upstream regulator of HTRA1. Mechanistically, lncRNA NEAT1 sponged miR-141-3p to positively regulate HTRA1 in a competing endogenous RNA (ceRNA) mechanisms-dependent manner. The recovery experiments in hESCs from NE and EE tissues confirmed that lncRNA NEAT1 overexpression promoted NLRP3 inflammasome-mediated pyroptotic cell death through regulating the miR-141-3p/HTRA1 axis. Taken together, this study firstly uncovered the underlying mechanisms by which a novel lncRNA NEAT1/miR-141-3p/HTRA1-NLRP3 pathway contributed to the development of EM, which provided novel diagnostic and therapeutic biomarkers for this disease.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (41)
- Altered p16Ink4a, IL-1β, and Lamin b1 Protein Expression Suggest Cellular Senescence in Deep Endometriotic Lesions via openalex
- Bioinformatical analysis identifies PDLIM3 as a potential biomarker associated with immune infiltration in patients with endometriosis via openalex
- Clinical Management of Endometriosis via openalex
- Clinical Management of Endometriosis via openalex
- Deregulation of LOXL1 and HTRA1 Gene Expression in Endometriosis via openalex
- Estrogen Receptor β Modulates Apoptosis Complexes and the Inflammasome to Drive the Pathogenesis of Endometriosis via openalex
- Inflammasome as a Key Pathogenic Mechanism in Endometriosis via openalex
- Inhibition of the NLRP3 inflammasome by progesterone is attenuated by abnormal autophagy induction in endometriotic cyst stromal cells: implications for endometriosis via openalex
- LINC01018 and SMIM25 sponged miR-182-5p in endometriosis revealed by the ceRNA network construction via openalex
- LINC01116 promotes proliferation and migration of endometrial stromal cells by targeting FOXP1 via sponging miR‐9‐5p in endometriosis via openalex
- NLRP3 Inflammasome Activation of Mast Cells by Estrogen via the Nuclear-Initiated Signaling Pathway Contributes to the Development of Endometriosis via openalex
- NLRP3 inflammasome: a new therapeutic target for high-risk reproductive disorders? via openalex
- Pathogenesis Based Diagnosis and Treatment of Endometriosis via openalex
- Pyroptosis and inflammasomes in obstetrical and gynecological diseases via openalex
- Regulation of Inflammation Pathways and Inflammasome by Sex Steroid Hormones in Endometriosis via openalex
- W3080758841 via openalex
- W3087243951 via openalex
- W3092080734 via openalex
- W3101193315 via openalex
- W3134885188 via openalex
- W3187165599 via openalex
- W3202490299 via openalex
- W4210394489 via openalex
- W4211063256 via openalex
- W4211138424 via openalex
- W4286697402 via openalex
- W4294733070 via openalex
- W2191571312 via openalex
- W2593489095 via openalex
- W2803546279 via openalex
- W2926902798 via openalex
- W2946716477 via openalex
- W2947827747 via openalex
- W2950111581 via openalex
- W2954782052 via openalex
- W2970315729 via openalex
- W3025135158 via openalex
- W3035243583 via openalex
- W3045902275 via openalex
- W3046487719 via openalex
- W3048446878 via openalex
Cited by (2)
Source provenance
- europepmc
- last seen: 2026-06-13T06:22:48.782012+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-06-13T06:21:56.202062+00:00
License: CC0
· commercial use OK